Cross-presentation of a spread-defective MCMV is sufficient to prime the majority of virus-specific CD8+ T cells.
about
Cytomegalovirus Infection and Memory T Cell InflationT cell memory in the context of persistent herpes viral infectionsSustained CD8+ T cell memory inflation after infection with a single-cycle cytomegalovirus.A spread-deficient cytomegalovirus for assessment of first-target cells in vaccination.Deciphering the role of DC subsets in MCMV infection to better understand immune protection against viral infectionsInfluenza A virus infection of human primary dendritic cells impairs their ability to cross-present antigen to CD8 T cells.Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties.Dissecting the requirements for maintenance of the CMV-specific memory T-cell poolReport from the second cytomegalovirus and immunosenescence workshop.Lymph Node Macrophages Restrict Murine Cytomegalovirus DisseminationImpaired direct priming of CD8 T cells by donor-derived cytomegalovirus following kidney transplantation.Superior induction and maintenance of protective CD8 T cells in mice infected with mouse cytomegalovirus vector expressing RAE-1γ.Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms.True grit: programmed necrosis in antiviral host defense, inflammation, and immunogenicity.Exploiting human herpesvirus immune evasion for therapeutic gain: potential and pitfalls.Manipulation of NKG2D ligands by cytomegaloviruses: impact on innate and adaptive immune response.Murine cytomegalovirus immune evasion proteins operative in the MHC class I pathway of antigen processing and presentation: state of knowledge, revisions, and questions.Parameters determining the efficacy of adoptive CD8 T-cell therapy of cytomegalovirus infection.Understanding MHC class I presentation of viral antigens by human dendritic cells as a basis for rational design of therapeutic vaccines.Cytomegalovirus immune evasion of myeloid lineage cells.Tissue-specific control of latent CMV reactivation by regulatory T cells.The role of cDC1s in vivo: CD8 T cell priming through cross-presentation.An attenuated temperature-sensitive strain of cytomegalovirus (tsm5) establishes immunity without development of CD8(+) T cell memory inflation.CD8+ T cell programming by cytomegalovirus vectors: applications in prophylactic and therapeutic vaccination.Blocking Virus Replication during Acute Murine Cytomegalovirus Infection Paradoxically Prolongs Antigen Presentation and Increases the CD8+ T Cell Response by Preventing Type I IFN-Dependent Depletion of Dendritic Cells.Cooperation between Epstein-Barr virus immune evasion proteins spreads protection from CD8+ T cell recognition across all three phases of the lytic cycle.MHC class I cross-presentation by dendritic cells counteracts viral immune evasion.Batf3 transcription factor-dependent DC subsets in murine CMV infection: differential impact on T-cell priming and memory inflation.Niches for the Long-Term Maintenance of Tissue-Resident Memory T Cells.Murine CMV Expressing the High Affinity NKG2D Ligand MULT-1: A Model for the Development of Cytomegalovirus-Based Vaccines.
P2860
Q26786776-97449D25-5F34-4FD3-AE6B-30CF7A75D077Q26999125-9E13C412-0266-4403-8200-F69D12FE1E42Q31036586-3929EDE5-D036-4E16-83FC-BB0A0843ACABQ33964131-33A4D2D9-EE89-4408-8E94-D5B54566BE50Q33965560-E73E75C8-FA0F-43FC-ACB9-82EFFD79F77CQ34192846-F74B2C2F-1AE9-4B9F-9D71-3731C4FBECE5Q34360228-E6DCADDC-EE93-4CA6-B703-B1024A309707Q35158957-84A92ADB-0E5D-425A-935D-9160F7A351E6Q35568719-4F1DF903-7010-4745-905F-A085F09EBD7FQ35758610-A11EE650-C631-42B4-83C3-0C08659C9CC7Q37202784-6CBD62C6-9753-4C03-B152-97673369D8FAQ37236631-96BC33C2-78EC-4324-921F-094E835568F2Q37278451-1395104C-5AB7-4EC9-B325-6CF94011B8FEQ37603408-D4010723-80A4-4C20-8722-4745E473FC89Q37837495-4445E56B-A89C-4F5A-878D-E5456FA3DD4EQ38008345-DF64B0AC-74A7-4C80-A411-CEC01CF025B1Q38041963-261EFCAA-27D4-4307-9919-0A7EF959C96FQ38042835-3D201F10-2C37-43A6-9D76-3D7E222ABD1BQ38209325-00A6957A-4CDB-4D68-BFDA-815BA6EF032BQ38379995-4560E436-A1DE-47FC-A723-CA90F2163E86Q38630384-6E517CE7-F954-4036-8F31-10CF649FE3A8Q38759136-987EF71D-A7E4-4F8A-856B-C55CD4B32204Q39384845-E88337F5-6469-4FA8-AF2D-3AFD6DE1FA93Q39451749-4DB5E43A-C4E9-402E-A6B1-66FA80E11C26Q40441600-0DD6F70F-BBB3-4B76-AB01-C3970DC4D14DQ41807836-AF238163-0DA8-4008-9B5C-B15977064324Q42005441-52F5365B-43F1-44B3-8E46-A5B7F730D177Q51007637-A18CE8D4-DF0E-4109-AEB6-72ABA9CFD344Q55080099-791B140D-99C8-40E5-ADE9-123B1383CC5AQ55408876-2D2D3F96-5779-485A-B528-C9BD12FF79D9
P2860
Cross-presentation of a spread-defective MCMV is sufficient to prime the majority of virus-specific CD8+ T cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cross-presentation of a spread ...... f virus-specific CD8+ T cells.
@ast
Cross-presentation of a spread ...... f virus-specific CD8+ T cells.
@en
Cross-presentation of a spread ...... f virus-specific CD8+ T cells.
@nl
type
label
Cross-presentation of a spread ...... f virus-specific CD8+ T cells.
@ast
Cross-presentation of a spread ...... f virus-specific CD8+ T cells.
@en
Cross-presentation of a spread ...... f virus-specific CD8+ T cells.
@nl
prefLabel
Cross-presentation of a spread ...... f virus-specific CD8+ T cells.
@ast
Cross-presentation of a spread ...... f virus-specific CD8+ T cells.
@en
Cross-presentation of a spread ...... f virus-specific CD8+ T cells.
@nl
P2093
P2860
P1433
P1476
Cross-presentation of a spread ...... f virus-specific CD8+ T cells.
@en
P2093
Ann B Hill
Carmen M Doom
Elizabeth L Bonnett
Jane E Allan
P2860
P356
10.1371/JOURNAL.PONE.0009681
P407
P577
2010-03-12T00:00:00Z